Article
PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden.
Journal of the neurological sciences - 15 Dec 2007
Kostulas Konstantinos, Gretarsdottir Solveig, Kostulas Vasilios, Manolescu Andrei, Helgadottir Anna, Thorleifsson Gudmar, Gudmundsson Larus J, Thorsteinsdottir Unnur, Gulcher Jeffrey R, Stefansson Kari, Hillert Jan
Abstract excerpt
BACKGROUND: Genetic variants in Phosphodiesterase 4D (PDE4D) and 5-lipoxygenase activating protein (ALOX5AP) have been shown to confer risk of Ischemic Cerebrovascular Disease (ICVD) in Iceland. We investigated whether these variants associate with ICVD in Sweden. METHODS: Previously published PDE4D and ALOX5AP gene variants were genotyped for cases (685) and controls (751). In PDE4D this consisted of SNP41,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
